VALERIE FERNANDEZ COLON

Allopathic & Osteopathic Physicians|General Practice TRUJILLO ALTO, PR NPI 1962025528

General Payments — all program years on this page

$627.94

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 26
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $301.07 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $301.0717

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $25.001
2022 $100.001
2023 $201.877
2024 $301.0717

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096580611 Novo Nordisk Inc $19.43 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096757678 Novo Nordisk Inc $13.66 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097204535 Novo Nordisk Inc $22.25 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097513326 Novo Nordisk Inc $19.96 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104659717 AstraZeneca Pharmaceuticals LP $20.75 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104711913 AstraZeneca Pharmaceuticals LP $19.00 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105744272 AstraZeneca Pharmaceuticals LP $16.91 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114656330 Exact Sciences Corporation $13.51 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115903857 GlaxoSmithKline, LLC. $15.50 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116529570 GlaxoSmithKline, LLC. $17.15 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116589757 GlaxoSmithKline, LLC. $16.22 01/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116610416 GlaxoSmithKline, LLC. $15.18 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117552875 Amgen Inc. $20.88 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118250811 Boehringer Ingelheim Pharmaceuticals, Inc. $17.44 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118250813 Boehringer Ingelheim Pharmaceuticals, Inc. $18.47 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118250815 Boehringer Ingelheim Pharmaceuticals, Inc. $16.64 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135487446 Lilly USA, LLC $18.12 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.